Post-earnings recap
Reported
Thu, Oct 27, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's earnings report showed a strong EPS performance, significantly exceeding expectations. The stock reacted positively, rising 3.55%. Investors may view this as a sign of the company's resilience and potential for future growth, despite the lack of revenue details and guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.04 | N/A | +137.04% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their EPS results. However, they did not provide specific guidance for future performance.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to advance their pipeline of therapies.